And possibly due to a lack of consensus on the association of TRT and prostate cancer risk, PSA was only measured in 76% of patients receiving exogenous hormone (Jasuja, Bhasin, Reisman, Berlowitz, & Rose, 2015). The gene discussed is KLK3; the disease is prostate carcinoma.